Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis (A59522) - R2 - Effective July 1, 2024

Date Posted: July 11, 2024

This Local Coverage Article (LCA) has been revised under contractor numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).

Effective Date: July 1, 2024

Summary of Changes:

Under CPT/HCPCS Codes Group 1: Codes added 0456U. This is due to the 2024 Q3 CPT/HCPCS Code Update and is effective 7/1/2024.

Under Article Text revised 3rd and 6th bullets to remove "DEX Z-Code™" and replaced with "DEX Z-Code®". Added "NOTE: When entering the DEX Z-Code® on the SV101-7 documentation field for Part B claims please do not add additional characters and/or information on the line".

This revision is due to the 2024 Q3 CPT/HCPCS Code Update and is effective 7/1/2024.

Visit the Noridian Active LCDs webpage to view the document or access it via the CMS MCD.

Last Updated Jul 11 , 2024